Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment

Claudia C. Dobler^*, Rebecca L. Morgan, Yngve Falck-Ytter, Victor M. Montori, M. Hassan Murad

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review